Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831596 · ClinicalTrials.gov registry record · NA
Evaluation of a Novel Post-Surgical Dressing
A NA study, sponsored by KCI USA.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT01831596: Clinical Trial NA study, sponsored by KCI USA.
NCT01831596 is a NA study that was terminated before completion, run by KCI USA. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01831596, a NA study, was terminated before completion, sponsored by KCI USA.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the Closed-Incision SNaP Device.
Primary Outcome
Frequency of complaints about device use and operation
Interventions
- DEVICE ciSNaP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Why NCT01831596 stopped before completion
NCT01831596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which ciSNaP is the first listed.
NCT01831596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01831596 about?
NCT01831596 is a clinical study titled "Evaluation of a Novel Post-Surgical Dressing". The purpose of this study is to evaluate the safety and efficacy of the Closed-Incision SNaP Device.
What is the current status of trial NCT01831596?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2010-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01831596?
The interventions under investigation include: ciSNaP (DEVICE).
Who is sponsoring clinical trial NCT01831596?
This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01831596's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia